Global Extended Release Drugs Market By Release Mechanism (Sustained-Release (SR) and Controlled-Release (CR)), By Therapeutic Area (Cardiovascular, Central Nervous System (CNS) & Psychiatric, Pain Management, Endocrine & Metabolic, Gastrointestinal, Anti-Infective, Respiratory and Others), By Formulation Techniques (Matrix Formulations, Coating Techniques and Encapsulation Techniques), By Distribution Channel (Retail Pharmacies, Hospital Pharmacies and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Global Extended Release Drugs Market size is expected to be worth around US$ 112.5 Billion by 2034 from US$ 53.6 Billion in 2024, growing at a CAGR of 7.7% during...